Prevest Denpro Limited Announces Resignation of Company Secretary and Compliance Officer

1 min read     Updated on 07 Apr 2026, 01:44 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Prevest Denpro Limited has announced the resignation of Company Secretary and Compliance Officer Mr. Aman Sadhotra, effective April 6, 2026. The resignation was submitted to pursue personal growth and professional development opportunities. The company has complied with all SEBI regulatory requirements and provided necessary disclosures to the stock exchanges.

powered bylight_fuzz_icon
37052066

*this image is generated using AI for illustrative purposes only.

Prevest Denpro Limited has announced the resignation of its Company Secretary and Compliance Officer, marking a significant change in the company's key managerial personnel.

Key Personnel Change Details

Mr. Aman Sadhotra (Membership No.: A66562) has tendered his resignation from the position of Company Secretary and Compliance Officer of Prevest Denpro Limited. The resignation becomes effective from April 6, 2026, following the closure of business hours on that date.

Parameter: Details
Officer Name: Mr. Aman Sadhotra
Membership Number: A66562
Position: Company Secretary and Compliance Officer
Effective Date: April 6, 2026
Reason: Personal growth and professional development

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Managing Director Atul Modi (DIN: 00788272) signed the official intimation letter to BSE Limited on April 6, 2026.

The resignation letter submitted by Mr. Sadhotra explicitly states his decision to step down from the role to pursue new opportunities for professional and career development. The company has confirmed that there are no material reasons for the resignation beyond those mentioned in the official resignation letter.

Official Statements and Acknowledgments

In his resignation letter dated April 6, 2026, Mr. Sadhotra expressed gratitude to the management for their continuous support, guidance, and the valuable learning experiences during his tenure with the company. The resignation has been formally accepted by the Board of Directors.

The company has ensured compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, providing all required disclosures and documentation. The information has also been made available on the company's official website as per regulatory requirements.

How quickly will Prevest Denpro appoint a replacement Company Secretary to ensure continuity in compliance functions?

Could this leadership change signal broader organizational restructuring or strategic shifts within the company?

What impact might the temporary absence of a Company Secretary have on Prevest Denpro's regulatory filings and governance processes?

Prevest DenPro Board Approves Q3FY26 Financial Results for Quarter Ended December 31

1 min read     Updated on 14 Feb 2026, 11:18 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Prevest DenPro Limited successfully concluded its board meeting on February 14, 2026, approving unaudited standalone and consolidated financial results for Q3FY26 quarter ended December 31, 2025. The meeting addressed regulatory compliance under SEBI regulations, with statutory auditors Mittal & Associates providing limited review reports for the consolidated structure including subsidiaries.

powered bylight_fuzz_icon
32197984

*this image is generated using AI for illustrative purposes only.

Prevest DenPro Limited has successfully concluded its board meeting held on February 14, 2026, approving the unaudited financial results for the quarter ended December 31, 2025. The meeting, which commenced at 03:30 p.m. and concluded at 04:05 p.m., addressed key regulatory compliance matters as previously scheduled.

Board Meeting Outcomes

The board of directors transacted and approved the following business matters during the meeting:

Agenda Item: Details
Financial Results: Approved unaudited standalone and consolidated financial results for quarter ended December 31, 2025
Auditor's Report: Approved limited review report of statutory auditors for Q3FY26 results
Meeting Duration: 35 minutes (03:30 p.m. to 04:05 p.m.)
Compliance: Under Regulations 30 and 33 of SEBI LODR 2015

Statutory Auditor's Review

Mittal & Associates, Chartered Accountants (FRN: 106456W), conducted the limited review of both standalone and consolidated financial results. Partner Sourabh Bagaria (Membership No 183850) signed the review reports, confirming compliance with Accounting Standard 25 Interim Financial Reporting and SEBI Listing Regulations.

Consolidated Financial Structure

The consolidated financial results include the following entities under the group structure:

Entity Type: Company Name
Holding Company: Prevest Denpro Limited
Subsidiary: Denvisio Biomed Limited
Subsidiary: Axiodent Inc.
Subsidiary: Prevest Denpro Gulf General Trading LLC

The auditor's report specifically mentions that Axiodent Inc. contributed total revenues of ₹10.24 lakhs for the quarter, while Prevest Denpro Gulf General Trading LLC reported no revenue during this period.

Regulatory Compliance

Company Secretary and Compliance Officer Aman Sadhotra digitally signed the regulatory communication, ensuring proper documentation and compliance with BSE requirements. The company trades on BSE SME platform under scrip number 543363 with the symbol PREVEST.

The unaudited financial results and statutory auditor's limited review reports have been submitted to BSE Limited for record and dissemination to all stakeholders as required under SEBI regulations.

More News on Prevest Denpro